-
公开(公告)号:US20200223916A1
公开(公告)日:2020-07-16
申请号:US16746725
申请日:2020-01-17
发明人: Hiroshi Eguchi , Takashi Murakami , Naoko Namiki , Akira Tanokura , Jeanne E. Baker , Sophie Parmentier Batteur , Angela Marie Jablonski , Daniel Stephen Malashock , Carl Mieczkowski , Gopalan (Raghu) Raghunathan
摘要: The invention provides methods for using and compositions of humanized antibodies that bind tau protein that is phosphorylated at the serine at position 413.
-
公开(公告)号:US10556950B2
公开(公告)日:2020-02-11
申请号:US15906773
申请日:2018-02-27
发明人: Hiroshi Eguchi , Takashi Murakami , Naoko Namiki , Akira Tanokura , Jeanne E. Baker , Sophie Parmentier Batteur , Angela Marie Jablonski , Daniel Stephen Malashock , Carl Mieczkowski , Gopalan (Raghu) Raghunathan
摘要: The invention provides methods for using and compositions of humanized antibodies that bind tau protein that is phosphorylated at the serine at position 413.
-
公开(公告)号:US20140242147A1
公开(公告)日:2014-08-28
申请号:US14349512
申请日:2012-10-05
发明人: Yasumi Nishiwaki , Takashi Murakami , Nobuaki Eto , Keiichiro Imaizumi , Akihito Ohtaki , Kenji Shimazaki
CPC分类号: A61K9/70 , A61K33/44 , B01J20/20 , B01J20/28004 , B01J20/28023 , B01J20/28066 , B01J20/28069 , B01J20/2808 , C01B32/336 , D01F9/14
摘要: The present invention aims to provide an adsorbent for oral administration comprising ACF that has high adsorption or removal performance by adsorbing or removing toxic substances in the living body greatly and rapidly. The present invention is an adsorbent for oral administration comprising activated carbon fibers for treating or preventing kidney diseases or dialysis complications.
摘要翻译: 本发明的目的在于提供一种口服给药用吸附剂,其特征在于,通过大量,快速地吸附或去除活体内的有毒物质,具有吸附或除去性能高的ACF。 本发明是用于口服给药的吸附剂,其包含用于治疗或预防肾脏疾病或透析并发症的活性炭纤维。
-
公开(公告)号:US20210380677A1
公开(公告)日:2021-12-09
申请号:US17122325
申请日:2020-12-15
发明人: Hiroshi Eguchi , Takashi Murakami , Naoko Namiki , Akira Tanokura , Jeanne E. Baker , Sophie Parmentier Batteur , Angela Marie Jablonski , Daniel Stephen Malashock , Carl Mieczkowski , Gopalan (Raghu) Raghunathan
摘要: The invention provides methods for using and compositions of humanized antibodies that bind tau protein that is phosphorylated at the serine at position 413.
-
公开(公告)号:US10894829B2
公开(公告)日:2021-01-19
申请号:US16746725
申请日:2020-01-17
发明人: Hiroshi Eguchi , Takashi Murakami , Naoko Namiki , Akira Tanokura , Jeanne E. Baker , Sophie Parmentier Batteur , Angela Marie Jablonski , Daniel Stephen Malashock , Carl Mieczkowski , Gopalan (Raghu) Raghunathan
摘要: The invention provides methods for using and compositions of humanized antibodies that bind tau protein that is phosphorylated at the serine at position 413.
-
公开(公告)号:US09682046B2
公开(公告)日:2017-06-20
申请号:US14349512
申请日:2012-10-05
发明人: Yasumi Nishiwaki , Takashi Murakami , Nobuaki Eto , Keiichiro Imaizumi , Akihito Ohtaki , Kenji Shimazaki
CPC分类号: A61K9/70 , A61K33/44 , B01J20/20 , B01J20/28004 , B01J20/28023 , B01J20/28066 , B01J20/28069 , B01J20/2808 , C01B32/336 , D01F9/14
摘要: The present invention aims to provide an adsorbent for oral administration comprising ACF that has high adsorption or removal performance by adsorbing or removing toxic substances in the living body greatly and rapidly. The present invention is an adsorbent for oral administration comprising activated carbon fibers for treating or preventing kidney diseases or dialysis complications.
-
-
-
-
-